BioCentury | Dec 13, 1999
Company News

bioLeads board of directors update

...Drug discovery Appointed: Alfred Bach, CEO of BASF-Lynx AG, as chairman; Herbert-Ernst Finke, partner at Hannover Finanz Group...
BioCentury | Sep 27, 1999
Finance

Neuer Markt angst

...$6.9 million) in venture financing for its programs for lead discovery from biological sources from Hannover Finanz Group...
Items per page:
1 - 2 of 2
BioCentury | Dec 13, 1999
Company News

bioLeads board of directors update

...Drug discovery Appointed: Alfred Bach, CEO of BASF-Lynx AG, as chairman; Herbert-Ernst Finke, partner at Hannover Finanz Group...
BioCentury | Sep 27, 1999
Finance

Neuer Markt angst

...$6.9 million) in venture financing for its programs for lead discovery from biological sources from Hannover Finanz Group...
Items per page:
1 - 2 of 2